B. Braun Dialog+ bloodline early alert: three Streamline Bloodline Set lots removed over connector detachment risk
Published November 8, 2026 · Coverage November 1–7, 2026, Pacific · High priority
FDA issued an Early Alert on a potentially high-risk device issue: B. Braun Medical Inc. has recommended to customers that lots A2600099, A2600128 and A2600136 of its Streamline Bloodline Set for Dialog+, model SL-2010M2096, be removed from where they are used or sold. B. Braun stated that a required solvent application step during assembly was not performed, leaving the dialyzer connector inadequately bonded, so the bloodline connector may detach or leak during priming or dialysis treatment, potentially leading to blood loss, clotting and occlusion of the extracorporeal circuit, or air entering the blood circuit. B. Braun sent customers a letter on October 20, 2026, and the earlier article reported FDA's device-safety listing of the alert on October 27, 2026.
Current status
On November 10, 2026, the FDA page, now at a new address, showed content current as of November 2, 2026, within this edition's November 1 to 7 coverage period, and FDA's list of recalls and early alerts showed the alert in a row dated November 2, 2026. The page lists the model, the three lots, two unique device identifier (UDI) codes labeled UDI-DI, and the recommended actions, and says B. Braun had reported no serious injuries or deaths associated with this issue as of October 10.
Who this affects
Dialysis units using Streamline Bloodline Set for Dialog+ model SL-2010M2096
Why it matters
A set from an affected lot can come apart or leak during treatment; FDA's page says hemodialysis patients are medically fragile, that extracorporeal blood loss may require clinical assessment, corrective treatment, professional medical intervention or hospitalization, and that in severe cases significant blood loss could be life-threatening. Inference: dialysis units need enough unaffected sets to replace any stock they quarantine and return.
Recommended action
- Inform all users; identify and quarantine affected devices (FDA)
- Determine inventory, cease use, quarantine and return affected product (manufacturer letter as described by FDA)
Scope and timing
- Authority status
- Other (FDA early alert)
- Responsible owner
- Dialysis services, Supply chain
- Publication date
- 2026-10-27 (FDA listing date as the earlier article states; the FDA list read on November 10, 2026 shows 11/02/2026)
- Other dates
- 2026-10-20 manufacturer letter; FDA page content current 2026-11-02
Not established
What FDA changed on the page on November 2 is not established. B. Braun's letter to customers was not retained.
Earlier article: November 4, 2026 edition →
Sources
Complete edition and supplemental material
This article in the complete report →
Executive triage, source-coverage limitations, context and forward horizons remain in the complete report.
Read the entire Compliance Sweep report →